Regulation of human NK-cell cytokine and chemokine production by target cell recognition
Top Cited Papers
Open Access
- 18 March 2010
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 115 (11) , 2167-2176
- https://doi.org/10.1182/blood-2009-08-238469
Abstract
Natural killer (NK)–cell recognition of infected or neoplastic cells can induce cytotoxicity and cytokine secretion. So far, it has been difficult to assess the relative contribution of multiple NK-cell activation receptors to cytokine and chemokine production upon target cell recognition. Using Drosophila cells expressing ligands for the NK-cell receptors LFA-1, NKG2D, DNAM-1, 2B4, and CD16, we studied the minimal requirements for secretion by freshly isolated, human NK cells. Target cell stimulation induced secretion of predominately proinflammatory cytokines and chemokines. Release of chemokines MIP-1α, MIP-1β, and RANTES was induced within 1 hour of stimulation, whereas release of TNF-α and IFN-γ occurred later. Engagement of CD16, 2B4, or NKG2D sufficed for chemokine release, whereas induction of TNF-α and IFN-γ required engagement of additional receptors. Remarkably, our results revealed that, upon target cell recognition, CD56dim NK cells were more prominent cytokine and chemokine producers than CD56bright NK cells. The present data demonstrate how specific target cell ligands dictate qualitative and temporal aspects of NK-cell cytokine and chemokine responses. Conceptually, the results point to CD56dim NK cells as an important source of cytokines and chemokines upon recognition of aberrant cells, producing graded responses depending on the multiplicity of activating receptors engaged.Keywords
This publication has 60 references indexed in Scilit:
- Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptorsBlood, 2009
- The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humansThe Journal of Experimental Medicine, 2009
- Natural killer cells in immunodefense against infective agentsExpert Review of Anti-infective Therapy, 2008
- Human natural killer cellsBlood, 2008
- Line of attack: NK cell specificity and integration of signalsCurrent Opinion in Immunology, 2008
- Stat4-dependent, T-bet-independent regulation of IL-10 in NK cellsGenes & Immunity, 2008
- HLA alleles determine differences in human natural killer cell responsiveness and potencyProceedings of the National Academy of Sciences, 2008
- Application of nine-color flow cytometry for detailed studies of the phenotypic complexity and functional heterogeneity of human lymphocyte subsetsJournal of Immunological Methods, 2008
- The PP2A inhibitor SET regulates natural killer cell IFN-γ productionThe Journal of Experimental Medicine, 2007
- Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulationBlood, 2005